Cart
sales@molnova.com
GSK-1482160
CAS No. 1001389-72-5
GSK-1482160( —— )
Catalog No. M35501 CAS No. 1001389-72-5
GSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 46 | Get Quote |
|
| 10MG | 72 | Get Quote |
|
| 25MG | 144 | Get Quote |
|
| 50MG | 255 | Get Quote |
|
| 100MG | 357 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-1482160
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity.
-
DescriptionGSK-1482160 is an orally available negative allosteric modulator of the P2X7 receptor. P2X7 receptors are involved in the production of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells. GSK-1482160 has the potential for the research of inflammation diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorP2X Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1001389-72-5
-
Formula Weight334.72
-
Molecular FormulaC14H14ClF3N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (298.76 mM; Ultrasonic )
-
SMILESCN1[C@@H](CCC1=O)C(=O)NCc1cccc(c1Cl)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ali Z, et al. Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br J Clin Pharmacol. 2013;75(1):197-207. doi:10.1111/j.1365-2125.2012.04320.x
molnova catalog
related products
-
AZ10606120 dihydroch...
AZ10606120 dihydrochloride has anti-depressant effects and reduces tumour growth.
-
AZD-9056
A potent, selective, orally bioavailable P2X7 receptor antagonist; inhibits release of pro-inflammatory mediators from isolated human peripheral monocytes (IL-1β and IL-18) and human alveolar macrophages (IL-1β) with IC50 values of 10-13 nM.
-
CE-224535
CE-224535 is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.
